Dr. Salgia on Next-Generation Sequencing in Lung Cancer

Ravi Salgia, MD, PhD, Arthur & Rosalie Kaplan Chair in Medical Oncology, associate director for clinical sciences at City of Hope, discusses the importance of next-generation sequencing for patients with lung cancer.

Next-generation sequencing can detect mutations, translocations, and amplifications, explains Salgia. The FDA has just approved one of the tests. It is important for the test to be in the tumor tissue, but there might not be enough tissue in the lung. If there is not enough tumor tissue, a liquid biopsy is a possible alternative, according to Salgia.